I am going to read this article for the seventh time and get back to you this week.
Tuesday, December 21, 2010
Genetic test may refine PSA or it may not!
Posted by
Steven Murphy MD
at
5:26 AM
2
comments
Labels: bachinsky, deCode, DTC Gen, genetic future, PSA, SNPs
Friday, June 11, 2010
I am glad we can all put this behind us. FDA rules on DTCG.
As you now may be aware. DTCG is considered a medical diagnostic according to the FDA. I look forward working with companies who may now allow me to use their tests for medicine.
Posted by
Steve Murphy MD
at
10:46 AM
0
comments
Labels: 23 and me, deCode, deCODEme, DNA direct, genetichub, navigenics, pathway genomics
Tuesday, November 17, 2009
Hey DTC genomics, Stay Private, Stay Alive, Go Public and Die

Today's lesson in start up business in the field of DTC Genomics is this.....
Posted by
Steve Murphy MD
at
7:53 AM
2
comments
Labels: 23 and me, deCode, deCODEme, navigenics
Wednesday, October 21, 2009
Excuse Me? Harvard and Navigenics? WTF?

Ok,
So I was blown away when I read this juicy little tid bit from Genome Web.
NEW YORK (GenomeWeb News) – Navigenics and Beth Israel Deaconess Medical Center in Boston announced today that they will collaborate on training physicians in personal genomic testing.
Amazing! I had spoken with Mike Murray up there a while ago and have neen involved in his training curriculum with CMEs for providers. I have always interpreted his opinion on the DTC companies to be suspect of what the hell the companies are doing.
In fact when we, Mike and I presented together at the Association of Program Directors in Internal Medicine meeting in 2008 in New Orleans I assumed that their department as well as he didn't much support DTC genomic testing.
Which is why the BID move had me puzzled, so I emailed him. But I also read further.....
As part of the program, residents will be given the opportunity to have their own genomes analyzed through Navigenics' consumer genomics services.
"We believe that genetics and genomics will be critical to the future of health care," Mark Boguski, of BIDMC's Department of Pathology and the Center for Biomedical Informatics at Harvard Medical School, said in a statement. "Training our residents on the leading genetic services and technologies will be essential to this future."
Ahh, I see. It is not the Genetics department who is involved with this. It is the pathologists, you know, the physicians who look at microscopic slides and run the clinical laboratories who are behind this.........
This Makes all the sense in the world now, non clinical geneticists teaching doctors about clinical genetics and how to use a self-avowed NONCLINICAL, NONMEDICAL test to learn medical genomics.....What the hell is Harvard thinking? I wonder if they received a nice endowment gift from the VCs who fund Navi????
So let me get this straight, Harvard Medical School sponsored Medical Residency at Beth Israel Deaconess is using a NONCLINICALLY validated test, from a company who states that the test should NOT BE USED FOR MEDICINE, to teach MEDICAL residents. To quote the plan
"Among the specific goals of the program are fostering an understanding of issues related to the evaluation of direct-to-consumer genotyping services and familiarizing physicians with the interpretation of genomic information and its correlation with personal medical and health information."
Have they lost their minds???? Shouldn't this be something that the clinical genetics department should be teaching? I wonder if Vance received a faculty position for this horse$h!t?
The Sherpa Says: I knew that this wouldn't come from the clinical genetics side. I hope they don't have any fingerprints on this one.....But my guess is Raju is involved in this one some how.....Now Harvard is confusing what is Important.
Posted by
Steve Murphy MD
at
8:10 AM
4
comments
Labels: 23andme, deCode, deCODEme, navigenics, pathway genomics
Tuesday, June 23, 2009
Watch Out Corporate Bloggers, FTC is on to you!

Now not only am I bashing corporate bloggers (Some may even call me corporate) Now the Federal Trade Commission has gotten into the game. It turns out that the FTC is on to the game of freebies for good blogging.
So to all of you who took free Navi or 23andMx or DeCodeme scans in hopes of them getting good press on your blog, you may have some issues. At least if you are in the US.....
From the Yahoo News
What some fail to realize, though, is that such reviews can be tainted: Many bloggers have accepted perks such as free laptops, trips to Europe, $500 gift cards or even thousands of dollars for a 200-word post. Bloggers vary in how they disclose such freebies, if they do so at all.
The practice has grown to the degree that the Federal Trade Commission is paying attention. New guidelines, expected to be approved late this summer with possible modifications, would clarify that the agency can go after bloggers — as well as the companies that compensate them — for any false claims or failure to disclose conflicts of interest.
So what does this mean for the genomics blogging world? A ton. I remember many, I mean many bloggers getting free kits. I also remember many people writing glowing reviews. I also know that the corporate blogs have been "inferring" things about what a genome scan can and cannot do........
The Sherpa Says: Just another case of government coming in and regulating for the protection of its citizens. Because of their commoners inability to sift through bull$h!t and hype. Time will tell what these new powers will do to the blogging community. I wonder what it will do for Twitter??? Wouldn't the government save a lot of money if they just made marketing illegal?
Posted by
Steve Murphy MD
at
5:15 AM
2
comments
Labels: 23andme, blogging, deCode, deCODEme, FTC, Helix Health of Connecticut, navigenics
Monday, June 15, 2009
The Genome Scan Dirty Little Secret

You know what I love, you take a company who is inferring that science IS clinical utility and then you hire them to perform interpretation on something that in it's current for is often uninterpretable......and then you sell that for something on the lines of 90-48, 000 USD.
My business is healthcare, my business is also risk prediction, but what my business is most is disease prevention......
My profession is physician, my oath is to do no harm and if I must harm, do so healing or palliating suffering....A noble profession to be sure.
But no one, I repeat no physician is leading the charge to do whole genome scans for risk prognostication.
Maybe for certain disease detection, but not for true risk prediction.
But, guess what? The business people are...... The business side of Genomics is all about getting "these little babies" into the hands of everyone......
Billions of people at 99 dollars a piece is a lot of money.....but the one thing that may hobble this model is what I like to call the dirty little secret of whole genome scanning.
You can read about it at my other posts
1. We have no clue what it really means.....Merry Christmas
2. Nature is So Wrong
3. Ok Guys, Seriously.
4. Rading the Medical Commons, A Pirate's Life for Me
Or you can let me recap. Currently DTC genomic companies are testing 1 million single nucleotide polymorphisms. We have in our body combined, 6 billion of these little nucleotides....
Sure the SNPs were safe, heck a SMALL minority had some science behind them.....but most were razzle dazzle and hyped by researchers to the press.....
Oversold and Overhyped.......If you thought that was something, wait to see the hype from the "Whole Genome" crowd.....
You see, even the most skilled, erudite, knowledgeable geneticist can be hobbled by the explanation of certain genomic changes......
A. If they changes often aren't in genes, then the biology needs to be elucidated, that takes years.
B. If the changes are in genes but that no one has seen before, how do you know what to predict will happen?
C. If we see a change which has been seen but has a wide variety of phenotypes, how do we explain the risk?
D. Most importantly, how do we modify disease risk based on genomic information for most of these things?????
My point is, you have disparate DTC companies calculating risks in different ways and even worse, recommending or "inferring" recommendations for lifestyle changes. Unfortunately, the quit smoking and lose weight isn't exactly "Science" or medicine, which is why they can get away with it.....
What about when a whole genome comes along at 30x coverage? Well, Illumina plans to do that and "outsource" the interpretation to these companies who are "interpreting" based on some very, very soft science already.
What in the hell do they plan to do with this whole genome interpretation?
In my mind these are the keys to get whole genome scan to utility.
1. Formalize some sort of standard interpretive algorithm AND THEN TEST IT CLINICALLY
2. Research the phenotypes which emerge from each and every genomic change out there.....Some like George Church plan to do this in the wide open....which may not attract the millions of people and dozens of years needed for this one....
3. Study the actions which will be proposed for each of the genomic changes to reduce disease risk or to treat disease.....
IFF you can get 5 common diseases captured with this, then you will have a successful system. But then the problem with this is what Illumina already knows...."you will be diagnosing disease and thus enter the realm of clinical test"
Which they have already prepared for by mandating physician ordering of their whole genome scan....
A long post I know......And a long way to go before this is useful at 99 USD per person.
The Sherpa Says: The incidentalome is just the beginning of the nightmare about to be unleashed with whole genomes.....
Posted by
Steve Murphy MD
at
8:21 AM
2
comments
Labels: 23 and me, affymetrix, deCode, deCODEme, Helix Health of Connecticut, illumina, navigenics
Wednesday, June 10, 2009
Consumer Genomics Spin

Thank God for Dan Vorhaus AKA @GenomicsLawyer on Twitter and a nice wrap up by Emily Singer
But like a groupie believing everything one reads, I want to caution those who attend that conference.
I heard major exaggerations and one might even say misstatements from the people presenting.......
The biggest one upset me. I am a fan of Jeff Gulcher's. I think he is a great guy. And his 1 in 100,000 story about finding aggressive prostate ca because of his SNP risk is very real. But, he claimed something which had been proven incorrect.
It had been proven incorrect months ago...... Maybe he did what DTC does best.....they imply things...... Jeff implied that their SNPs for CVD actually reclassify women's risk......
In order to prove that he would need a cohort and he would have to control for all other things AND he would have to have been studying this cohort for about 20 years.....which to my recollection has not happened with deCode.....
More importantly, the SNP they discovered was not found to add ANYTHING useful to the current classification system for risk of heart attack....
However, there is something which reclassifies approximately 40% of women and 17-20 percent of men......the Reynolds Risk Score, studied by Paul Ridker et.al. up at Harvard....
In this great example, clinical risk factors are combined with genetic factors, in this case Family History and it outperforms Framingham Risk Stratification........
But to state that their tests perform the same or even to insinuate this, well, that's just intellectually dishonest and I wouldn't expect that from Jeff......which means he "must have been mistaken"
So today I look forward for more exaggeration at CGS as I call in to the ICOB meeting for the Coriell Personalized Medicine Collaborative......I implore others to follow Dan @genomicslawyer and look for the same.
The Sherpa Says: We must always listen with a critical ear to what is said by people with money or power or both......
Posted by
Steve Murphy MD
at
4:38 AM
0
comments
Labels: 23 and me, cpmc, deCode, Helix Health of Connecticut, navigenics, reynolds risk
Monday, June 8, 2009
rs2200733 ok, now what?

I am busy pouring through all sorts of association studies which I had let sort of slip through my fingers. I have been cue'ing a lot of these and only in the last few days have been able to get to them. Most of the SNP that the press put out there now seems to be dying off pretty nicely.
Although there are bits of useful data out there, most is just noise......but one of the SNPs which caught my eye was rs2200733 studied in Icelandic, Italian and other Caucasian populations with a small replication in an Asian population as well......What does rs2200733 predispose to?
Atrial Fibrillation. A condition that can lead to unannounced strokes, syncope, and heart failure (at times) Atrial fibrillation is the most common arrhythmia in the United States.
About 2.3 million Americans have atrial fibrillation (Go, 2002). Men have a 50% higher incidence than women at any age (Benjamin, 1994). Among individuals 50 years of age and older, the prevalence is higher for Caucasian individuals than African Americans.
The prevalence of atrial fibrillation is 0.1% for individuals under age 55 and 9.0% for individuals over the age of 80 (Go, 2002). HT CPMC.....
Here's why I am revisiting it? It popped up on my screen as a SNP with a study which purported an Odds Ratio greater than 2...... In my mind, no SNP should be even looked at without having this.....why?
Well, most clinical scenarios have
1. Good risk prediction tools already, as with the 9p21.3 issue
2. No true benefit of presymptomatic detection, i.e. no effective prevention (Parkinson's)
3. No ability to guide therapeutic decision making..... This is true in 99% of cases, aside from pharmacogenomics that is.......
So why am I looking again at rs2200733? Because this may actually be a case where I think it may augment my other clinical tools of prediction......Maybe.
Why only maybe?
A. Most of my patients get annual physicals with annual EKGs.....and often AFIB manifests with symptoms....
B. Most of the patients with AFIB are elderly and in the studies some indicate earlier AFIB pops, some don't which may be confounding in the study
C. Most of the people with AFIB that I see report a family history of some sort of arrythmia, most often AFIB.....
That being said, there is a population <10% who end up with No family history, Present Early and present with a stroke....It is rare, but does happen.....so I naturally would want to watch that population more than not......But does that mean I should do "More" for them?
In the age of Comparative Effectiveness, I may not be allowed to..........There is no ICD9 code for genetic predisposition to Atrial Fibrillation......
But maybe people would pay more than the 20 dollar copay for care???? Probably not that often, but maybe.....And for what? A home monitor to be hooked up on them 24/7?
It turns out
DeCode sells a test with this SNP, Is on the Affy and Illumina Chips, I.E avail for 23andM- and Navi.............
None of these are actually valid clinical tests yet though.....Similar to other "clinical" detection tools we have today.
So what I am going through is in essence mental acrobatics while I await a company to do a study which proves that there is some benefit and some action to be taken here.......
The Sherpa Says: While a promising SNP is out there, it is just that a promising SNP. Most of these things won't affect me clinically for another 5 years. I wonder what the public will do with this data? Will they go see a doctor? Who ultimately would be asking the same question I am.....and waiting for the same data
Posted by
Steve Murphy MD
at
5:05 AM
0
comments
Labels: 23 and me, deCode, deCODEme, DNA direct, dna dynasty, Helix Health of Connecticut, navigenics, rs2200733
Tuesday, March 10, 2009
Why Is Healthcare so Expensive?
Posted by
Steve Murphy MD
at
11:52 AM
1 comments
Labels: 23andme, deCode, DNA direct, Helix Health of Connecticut, medicare, navigenics
Wednesday, December 31, 2008
2009, Kansas is going Bye Bye!
Finally, what you all have been eagerly anticipating.
The Sherpa's Predictions for 2009.
Mind you they come in 3 groups. Highly likely, Possible and Ridiculous
Highly Likely:
1. Francis Collins will become the director of the NIH and collaborate with Kari from Iceland to create a national database of genomes. This is the only way to jumpstart personalized medicine. My feeling is that Kari knows how to do this, is a friend of Francis, and Obama is likely to give him the greenlight on this, despite public sentiment....
2. We will see our first lawsuit for a pharmacogenomic cause. My colleague over at ASU, Gary Marchant says it will only take one and the flood gates will open. The lawsuit will be based on something called "Loss of Chance" doctrine. The theory goes, "did you cause the patient to lose a chance at a better health outcome?" If the answer is yes, well then you can be sued. This recently has been the case for delayed diagnoses in several states (24 to be precise). All it takes is one smart, enterprising, hungry attorney to go after this....I can see it now.
Plantiff's attorney(PA) "Doctor, who is the FDA?"
Doctor(MD): "The US Food and Drug Administration"
PA "and what do they do?"
MD: "FDA provides safety information on drugs and other FDA-regulated products, and allows for adverse event reporting."
PA: "Would you use a drug that was not approved by the FDA?"
MD: "No"
PA: "Doctor, would you mind reading this label?"
MD: "…genetic variations in the CYP2C9 and VKORC1 enzymes may influence the response of the patient to warfarin.” In the “Dosage and Administration” section, it states that lower initial doses should be considered for patients with genetic variations in CYP2C9 and VKORC1."
PA: "Doctor, what is the genotype of the defendant Mr. X?"
MD: Silence....
PA: "Doctor?"
MD: "I do not know"
PA: "Doctor, why do you not know everything you need to know about a patient PRIOR to giving this deadly rat poison"
MD: Silence
PA: "Doctor, is there evidence showing that patients with poor metabolism would need a lower dose than the one you prescribed Mr. X?"
MD: "Yes, but......"
PA: "But what doctor? Why would the FDA put something on the label if there wasn't solid evidence behind it?"
PA: "furthermore, if you knew your patient had a liver problem with metabolizing the medication, would you give the dose you gave to Mr. X?"
MD: "Well, hepatic dysfunction is (cut off by attorney)
PA: "CYP2C9 genetic mutations ARE hepatic dysfunction doctor"
I think you get where I am headed. In economic lean times, people will try anything....and this sure is like the Statue of Liberty play. It WILL score a touchdown, that's why people still run it.
3. We will see George Church's Exome project results and they will certainly confuse all of us as to what it really means. We may even see a broken ladder?
Possible:
1. We will have an X-Prize winner. If PacBio and the black box known as Complete Genomics work out, this will be ready by November 2009. Seriously.....now, to sort out what the hell it means......We need a database, someone to actually take liability (Unlike the chickeSh!^ companies today), and someone to counsel on this.....do you really think 2700 people is enough???? That is only a cool 111,533 people per provider......at 2 hours per evaluation that is only 223,066 hours of work, only 9294 days of straight work, or 25 years straight!.....give me a freakin break NSGC/ABMG/ABGC/ACMG!
2. Mr. Stoicescu sues KNOME for a 345,000 USD refund. It could happen, the oligarchs lost a ton of money last year. I am sure he could use the money back in exchange for Complete Genomics Genome evaluation.
3. Oprah will have a third hoax on her hands as she discovers her genome scan was bogus. 3 strikes and your out Oprah!
Ridiculous:
1: Mark Cuban will buy the rights to 23andMe's database. If I have at least one thing, it is tenacity.....this one will happen
2: A new technology called next-next-next-next gen sequencing will debut and have your genome done in 15 minutes. They will say the technology will be ready for prime time in 2 years.
3. The United States will fracture into 6 territories controlled by Russia, Mexico, China, Canada....I think I played this game in the 1980s.
The Sherpa Says: Happy New Year! May the new year be as good for you as it already has been for me. Here's to personalized medicine in 2009!!!!!
Posted by
Steve Murphy MD
at
9:13 PM
2
comments
Labels: 23andme, barack obama, coriell personalized medicine collaborative, deCode, francis collins, Helix Health of Connecticut, navigenics, recession
Saturday, December 27, 2008
Sherpa's Batting Average for 2008.
1. Jim Watson will die.
Well, only a few base pairs off on this one. The legend Victor McKusick did pass, God rest his soul.....Damn that 10x coverage.
2. Mark Cuban would buy the rights to 23andMe's genome database.....I knew he would do something dastardly.....only it was not genome stealing.....it was insider trading..
3. The X-Prize would be won by a little known start up........At that time I thought Pac Bio would be ready to launch.....Guess I was wrong....
6. Academia will start to market personalized medicine..........Duke, Harvard, Mayo, Scripps, Mount Sinai, UCSF, Stamford, Wisconsin, Ohio State all joined the ranks. I wonder why Yale is not there????
4 of 9, if you count legal proceedings from a state as getting sued......
Posted by
Steve Murphy MD
at
11:51 AM
7
comments
Labels: 23 and me, deCode, helicos, Helix Health of Connecticut, navigenics, pacific biosciences
Wednesday, December 24, 2008
We have no clue what it really means....Merry Christmas
Posted by
Steve Murphy MD
at
3:17 AM
5
comments
Labels: 23 and me, brave new world, deCode, francis collins, iceland, navigenics
Tuesday, December 16, 2008
Raiding the medical commons!!!! A pirate's life for me.
Posted by
Steve Murphy MD
at
3:10 AM
3
comments
Labels: 23 and me, coriell personalized medicine collaborative, deCode, Helix Health of Connecticut, navigenics
Thursday, November 6, 2008
Nature is so Wrong!
Nils over at SciPhu has decided to stop posting about DTC and his stance. Why would such a great scientist/blogger decide enough is enough? Nature made him do it...Huh? Yes Nature and its eloquent arguments about personal genomics......
It is virtually impossible to conceive of a sustainable form of healthcare that operates as the current systems in industrialized nations do. At present, healthcare is based on the late diagnosis of disease and the division of diseases into a few categories based on some overarching gross similarities. And it firmly places physicians as the central gatekeepers of information.
The healthcare of the future, on the other hand, if the technical potential to provide personalized medicine is ever to be realized, will probably require a greatly expanded emphasis on diagnosis and monitoring, early and subtle intervention, monitoring of the impact of intervention, and gradual adaptation of treatment with the evolving physiology, metabolism and lifestyle of the individual.
Faced with this huge expansion of data on ‘my’ health, it will simply not be affordable to maintain our dependence on medical gatekeepers, whether they are physicians or genetic counselors, without individuals taking a much greater responsibility for their own wellbeing. Whether the medical establishment likes it or not, it will be too cumbersome and too expensive to conduct personalized medicine if all diagnostic-to-therapeutic decisions depend on doctors.
Posted by
Steve Murphy MD
at
7:32 AM
3
comments
Labels: 23 and me, deCode, deCODEme, Helix Health of Connecticut, nature genetics, nature journal, navigenics
Wednesday, November 5, 2008
Genetic Test or Family History? Which Matters More?
To evaluate the effect of the genetic risk information source (family history vs genetic test results) on parents’ concern about their own and their children’s genetic disease risk.
Parents first received a vignette about their hypothetical genetic risk, randomized as either a family history assessment or genetic test results. Next, parents received a vignette about their youngest child’s hypothetical genetic risk, similarly randomized.
Imagine that you have family members with a disease that causes severe symptoms in adults. Having this “family history” means that (you/your youngest child) has a 30% chance of developing this disease. A 30% chance means that 3 out of 10 people will develop the disease.
“How concerned are you that (you/your child) might develop this disease?”
Imagine that (you/your youngest child)gets a genetic test result that says he/she has a 30% chance of developing a disease with severe symptoms in adults. A 30% chance means that 3 out of 10 people will develop the disease. “How concerned are you that (you/your child) might develop this disease?”
Parents were more likely (twice as likely) to be concerned about their own disease risk when
the risk estimate came from a family history assessment vs a genetic test result (odds ratio, 1.96; 95% confidence interval, 1.44-2.68).
Positive family history of disease generated greater concern about parents’ own risk of inherited
disease than did genetic test results.
Posted by
Steve Murphy MD
at
9:12 AM
2
comments
Labels: 23 and me, barack obama, burrill and company, coriell, deCode, Helix Health of Connecticut, navigenics
Tuesday, November 4, 2008
Daniel Ballon Off Course with DTC testing!
Don't believe me......look at the last month and the SNPs in 9p21 a region argued that is highly linked to heart attack.
1. linked to Irish heart disease
2. Failed to replicate in the Dutch
4. Now linked to Alzheimer's Disease if you believe it........
So which is correct? More importantly.....will testing this help us risk stratify any better? Will it help us treat any better? Will it help prevent disease? None of these questions have been answered scientifically yet.....Not a single one! No where is this mentioned in regards to validity, accuracy or reliability....yet these reports include risk assessments...based on these SNPs!!!!
Posted by
Steve Murphy MD
at
2:25 AM
1 comments
Labels: 23 and me, barack obama, coriell, deCode, Helix Health of Connecticut, john mccain, navigenics, newt gingrich






